Cost-effectiveness of macrolides in lower respiratory tract infections.
Dietrich
E S
ES
Voegele
T
T
Frank
U
U
Daschner
F D
FD
D000900:Anti-Bacterial Agents / Q000191:economics* / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy*; D003362:Cost-Benefit Analysis; D006801:Humans; D018942:Macrolides; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology
D000900:Anti-Bacterial Agents; D018942:Macrolides